#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Progressive multifocal leukoencephalopathy Guillain-Barre syndrome Palmar-plantar erythrodysaesthesia syndrome Arterial tortuosity syndrome Neuroblastoma recurrent Extra-osseous Ewing's sarcoma Myxoid liposarcoma Lymphoma Liposarcoma metastatic Undifferentiated sarcoma Cutaneous T-cell lymphoma Anal cancer Neurofibromatosis Neutropenia Meningococcal immunisation More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage IV – Basic Information Mantle cell lymphoma stage II – Life with Disease Osteosarcoma metastatic – Life with Disease Idiopathic pulmonary fibrosis – Trials in Disease Paroxysmal nocturnal haemoglobinuria Haemolytic uraemic syndrome – Treatment Pelizaeus-Merzbacher disease Burkitt’s lymphoma – Trials in Disease Angiosarcoma metastatic – Life with Disease Krabbe’s disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cetirizine Art0380 Mesilate REGN7999 Aaa802 Camizestrant Umeclidinium Irinotecan Hydrochloride Tenofovir Disoproxil Fumarate Treprostinil Sodium Zanidatamab Danicopan Salbutamol Cefepime Tazobactam Sodium Sodium Fluoride (18F) Naporafenib Atazanavir Sulpiride GSKVX000000070250 POTASSIUM CLAVULANATE More therapies…

    Learn about Your Condition

    Thromboangiitis obliterans Marginal zone lymphoma Peripheral artery restenosis Hyperparathyroidism secondary Autoimmune haemolytic anaemia Eructation Toxic nodular goitre Neurodevelopmental disorder Endocrine disorder Death neonatal Osteoporosis postmenopausal Pseudoxanthoma elasticum Progressive supranuclear palsy Hepatobiliary disease Breast cancer metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliero Universitaria Consorziale Policlinico…

Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari

Piazzale Giulio Cesare 11, Bari, 70124, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Long-Term Safety of Pimavanserin for Treating Irritability in Children and Adolescents with Autism Spectrum Disorder

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Pimavanserin Tartrate
    France Hungary Italy Poland Spain

  • Study on the Effects of Sparsentan and Irbesartan for Patients with Primary Focal Segmental Glomerulosclerosis (FSGS)

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Focal segmental glomerulosclerosis
    Investigated Drugs:
    • Irbesartan
    • Sparsentan
    Belgium Croatia Czechia Denmark Estonia France +6

  • Study of tovorafenib versus standard chemotherapy as first treatment for children with low-grade glioma with RAF gene changes

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant glioma
    Investigated Drugs:
    • Tovorafenib
    • Vinblastine Sulfate
    • Carboplatin
    Austria Belgium Czechia Denmark Finland France +10

  • Study on the Safety and Effectiveness of Metformin Hydrochloride, Dapagliflozin, and Canagliflozin in Elderly Patients with Type 2 Diabetes

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Canagliflozin
    • Metformin Hydrochloride
    • Empagliflozin
    Italy

  • Study on Carboplatin, Paclitaxel, Bevacizumab, and Rucaparib for Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Malignant peritoneal neoplasm
    • Ovarian cancer
    Investigated Drugs:
    • Rucaparib
    • Bevacizumab
    • Carboplatin
    Italy

  • Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Formoterol Fumarate
    • Formoterol Fumarate Dihydrate
    • Glycopyrronium Bromide
    Bulgaria Hungary Italy Poland Romania Spain

  • Study of Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Daratumumab
    • Dexamethasone Sodium Phosphate
    • Pomalidomide
    Italy

  • Study on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Rosnilimab
    Belgium Estonia France Germany Hungary Italy +3

  • Study of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Belzutifan
    • Cabozantinib
    • Lenvatinib
    Austria Belgium Czechia Finland France Germany +7

  • Study of Eptinezumab as Add-on Treatment for Prevention of Migraine in Adults with Both Migraine and Medication Overuse Headache

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Medication overuse headache
    • Migraine
    Investigated Drugs:
    • Eptinezumab
    Denmark France Germany Italy The Netherlands Norway +2
Previous Page
1 … 3 4 5 6 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!